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A vital part of biopharmaceutical research is decision making around which lead
candidate should be progressed in early‐phase development. When multiple anti-
body candidates show similar biological activity, developability aspects are taken
into account to ease the challenges of manufacturing the potential drug candidate.
While current strategies for developability assessment mainly focus on drug pro-
duct stability, only limited information is available on how antibody candidates with
minimal differences in their primary structure behave during downstream proces-
sing. With increasing time‐to‐market pressure and an abundance of monoclonal
antibodies (mAbs) in development pipelines, developability assessments should also
consider the ability of mAbs to integrate into the downstream platform. This study
investigates the influence of amino acid substitutions in the complementarity‐
determining region (CDR) of a full‐length IgG1 mAb on the elution behavior in
preparative cation exchange chromatography. Single amino acid substitutions within
the investigated mAb resulted in an additional positive charge in the light chain (L)
and heavy chain (H) CDR, respectively. The mAb variants showed an increased
retention volume in linear gradient elution compared with the wild‐type antibody.
Furthermore, the substitution of tryptophan with lysine in the H‐CDR3 increased
charge heterogeneity of the product. A multiscale in silico analysis, consisting of
homology modeling, protein surface analysis, and mechanistic chromatography
modeling increased understanding of the adsorption mechanism. The results reveal
the potential effects of lead optimization during antibody drug discovery on
downstream processing.
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1 | INTRODUCTION
In recent years, the number of monoclonal antibodies (mAbs) in-
vestigated in clinical studies has steadily increased (Kaplon
et al., 2020; Kaplon & Reichert, 2019). Manufacturing and material
supply for preclinical and clinical trials form a major building block in
biopharmaceutical product development and is often referred to as
chemistry, manufacturing, and controls (CMC). A recent cost eva-
luation performed by Farid et al. (2020) predicted that CMC activ-
ities represent 13%–17% of the total R&D budget from preclinical
trials to regulatory approval. Their calculation considered costs
caused by ~92% of candidates that fail during preclinical and clinical
development (Farid et al., 2020). Biopharmaceutical organizations
strive to streamline development by using computer‐aided sequence
optimization tools in drug discovery that increase the likelihood of
successful CMC programs within a strict timeframe (Bailly
et al., 2020; Bauer et al., 2020; van der Kant et al., 2017). Current
strategies for developability assessment rely on in silico techniques
to predict aggregation propensities, solubility issues, or long‐term
stability of the mAb product (Bauer et al., 2020; Seeliger et al., 2015).
Compared with stability aspects in formulation development, how
single amino acid substitutions in lead candidates may affect devel-
opability of the downstream process (DSP) is poorly understood.
Industrial DSP of biopharmaceuticals relies heavily on chroma-
tographic separation techniques. For the purification of mAbs, pre-
parative cation exchange (CEX) chromatography is frequently
employed as a polishing step (H. F. Liu et al., 2010; Shukla
et al., 2007). CEX chromatography allows the removal of process‐
related impurities, including DNA, host cell proteins, endotoxins, or
leached Protein A (H. F. Liu et al., 2010, 2011). Due to its high
selectivity toward protein charge, CEX chromatography can also
separate an antibody from its product‐related impurities, for
example, size or charge variants. Despite the favorable properties
regarding impurity removal, CEX chromatography remains one of the
most development‐intensive unit operations in the DSP. The com-
parably strong effect of a mAb's structural characteristics on elution
behavior in CEX chromatography demands an adaption of process
conditions for each product. Therefore, a significant body of research
has focused on understanding the relationship between protein
structure properties and adsorption behavior. Adsorption in protein
chromatography can be investigated using molecular dynamic si-
mulations (Dismer & Hubbuch, 2010; Lang et al., 2015). Monte Carlo
simulations performed by Zhou et al. (2004) showed that antibodies
tend to have a “head‐on” fragment antibody (Fab)2 binding orienta-
tion on negatively charged surfaces and an “end‐on” fragment crys-
tallizable (Fc) binding orientation on positively charged surfaces, at
high surface charge density and low salt concentration. In multimodal
(MM) systems, the chromatographic behavior and binding orienta-
tion of model proteins (Banerjee et al., 2017; Freed et al., 2011; Woo
et al., 2015) and mAbs (J. Robinson et al., 2018) depends on ligand
structure and surface properties of the molecule. Furthermore, J.
Robinson et al. (2020) showed that the domain contribution of mAbs
in MM chromatography is affected by the mobile phase pH value.
In contrast to qualitative analysis, quantitative structure–property
relationship (QSPR) models correlate structural descriptors with
chromatographic behavior by applying mathematical models. QSPRs
based on the crystal structure of non‐mAb proteins allowed the
prediction of protein retention times (Mazza et al., 2001) and ad-
sorption isotherm parameters (Ladiwala et al., 2005) in ion‐exchange
(IEX) chromatography. J. R. Robinson et al. (2017) applied QSPR
modeling to the purification of homologous Fab variants on MM
resins. Kittelmann et al. introduced an orientation sensitive QSPR
approach for model proteins (Kittelmann et al., 2017a) and mAbs
(Kittelmann et al., 2017b) in IEX chromatography. A comprehensive
study performed by Ishihara et al. (2005) investigated the elution
behavior of 28 mAbs in Protein A affinity and CEX chromatography.
For CEX chromatography, the salt concentrations at peak maximum
correlated with the surface positive charge distribution of the heavy
chain variable region (Ishihara et al., 2005). To the best of our
knowledge, results on how substituting residues within the adsorp-
tion relevant surface of a full‐length mAb would influence CEX
chromatography have not been published yet.
In contrast to structure‐based modeling techniques, mechanistic
models describe the physical effects in chromatography columns on a
macroscopic level. During the last years, mechanistic chromatography
modeling became a state‐of‐the‐art technology in biopharmaceutical DSP
development. Possible applications of mechanistic models are process
optimization (Hahn et al., 2014; Huuk et al., 2014), model‐guided scale‐up
(Benner et al., 2019; Mollerup et al., 2007), in silico robustness analysis
(Close et al., 2014; Jakobsson et al., 2007; Rischawy et al., 2019), or root
cause investigation (Wang et al., 2017). The process understanding
provided by mechanistic chromatography models enables in silico DSP
development in line with the Quality by Design (QbD) concept (Mollerup
et al., 2008). Chromatography models consist of partial differential
equations describing mass transport and protein adsorption phenomena.
For IEX chromatography, the adsorption can be modeled using the
stoichiometric displacement model (SDM) (Boardman & Partridge, 1955).
The SDM is based on the electrostatic equilibrium theory and formulates
the multipoint binding of proteins under consideration of displacement
effects. Brooks and Cramer (1992) extended the SDM toward the steric
mass‐action (SMA) model to cover the shielding effects of bound protein
on the resin surface.
Previous work has demonstrated the predictive power of SMA
models, even when extrapolating beyond the experimental conditions
applied for model calibration (Briskot et al., 2019). Despite the proven
predictive power and the mechanistic nature of the SMA model, it is not
clear which structural characteristics of mAbs influence adsorption model
parameters. For example, Rüdt et al. (2015) built an SDMmodel for an Fc
fusion protein and corresponding aggregates by assuming constant
characteristic charge values for both protein species. Other authors
(Borg et al., 2014; Briskot et al., 2019) reported differing characteristic
charge parameters for mAb size and charge variant, due to altering
numbers of charged groups interacting with the resin. Furthermore, it is
unclear if steric shielding is exclusively a function of the chromatographic
ligands blocked by the adsorbed protein or if it further considers non‐
adsorptive or repulsive effects (Ladiwala et al., 2005). Due to the missing
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correlations between adsorption isotherm parameters and structural
characteristics of multidomain proteins such as mAbs, the preferred
practice for model calibration often involves curve fitting to experimental
data (Briskot et al., 2019; Hahn, Huuk, et al., 2016). Substitution of single
charged amino‐acid side chains in the adsorption relevant region of full‐
length mAbs could elucidate the correlations between protein structure
and macroscopic adsorption model parameters.
The aim of the present work is to gain a deeper understanding of
the binding mechanism of mAbs in preparative CEX chromatography.
Therefore, multiple purification experiments were performed for a
full‐length IgG1 mAb, and two variants differing in a single amino
acid within the complementarity‐determining region (CDR). An ad-
ditional positive charge in the L‐ and H‐CDR of the mutated mAbs
increased their retention volume during linear salt gradient elution
(LGE). Potential effects of amino acid substitutions on the develop-
ability of the CEX unit operation were investigated in chromato-
graphy runs at low and high loading densities. Homology modeling
and protein surface analysis identified exposed mAb regions that
mediate the adsorption process. The data set enabled the estimation
of SMA model parameters for the three mAbs. The identified effects
of amino acid substitutions on adsorption model parameters could
support model calibration and QSPR modeling.
2 | METHODS
2.1 | Process conditions and mAbs
The mAb polishing step was performed on the strong CEX resin POROS
XS (Thermo Fisher Scientific). Column‐specific parameters and the
equations used for their calculation are listed in Table 1. Tracer injections
with blue dextran and 1M sodium chloride (both from Sigma‐Aldrich)
enabled the calculation of the interstitial volume, Vint and total liquid
volume, Vt, respectively. The ionic capacity Λ was determined by
acid–base‐titration (Huuk et al., 2016). Column characterization experi-
ments were conducted as triplicates. Chemicals used in this study were
of pharmaceutical grade. All buffers were prepared with deionized water
and filtered with a 0.2‐μm sterile filter. Column experiments were per-
formed on the preparative chromatography system ÄKTA Avant
25 controlled via Unicorn 7 (both from Cytiva). Sodium acetate buffer at
pH 5.25 was used for all preparative CEX experiments. The column was
equilibrated at pH 5.25 and a counterion concentration of 0.05M so-
dium. Buffer exchange of protein samples into the equilibration buffer
resulted in defined loading conditions. During gradient elution, counter‐
ion concentration increased from 0.05 to 0.50M sodium. The loading
density was 1 g/LResin for LGEs in the linear region of the adsorption
isotherm and 30 g/LResin for high loading density runs. Samples applied
for low and high loading experiments had protein concentrations of 1 and
3 g/L, respectively. Loading densities were adjusted via the applied
sample volume, considering the 10.68ml column volume. 1 and 0.1M
sodium hydroxide were used for column regeneration and storage,
respectively.
The three model proteins used in this study are IgG1 mAbs ex-
pressed in Chinese hamster ovary cells (Boehringer Ingelheim
Pharma GmbH & Co. KG). The mAbs were captured via Protein A
affinity chromatography. Two mutants (M1 and M2) with additional
positively charged groups in the CDRs were derived from a corre-
sponding wild‐type (WT) antibody. Surface charge of M1 was in-
creased by substitution of serine with lysine in the L‐CDR3. For M2,
a tryptophan in the H‐CDR3, was substituted with lysine. The amino
acid substitutions were introduced to affect the biophysical prop-
erties of the mAb via modification of surface‐exposed hydrophobic
and charged patches. This methodology can reveal the possible ef-
fects of mAb lead optimization on CMC properties in upstream,
downstream, and formulation development.
2.2 | Homology modeling and protein surface
analysis
Full‐length homology models of investigated mAbs were built in
Maestro BioLuminate 3.7 (Schrödinger) following the method
TABLE 1 Experimentally determined
system‐ and column‐specific model
parameters
Parameter Symbol Value Unit Equation References
Length L 136 mm ‐ ‐
Diameter d 10 mm ‐ ‐




Bead radius rp 25 µm ‐ ‐
Interstitial porosity ε col 0.41 ‐ ε =
V
Vcol
int Hahn, Huuk, et al. (2016)
Total porosity ε t 0.78 ‐ ε = VVt
t Hahn, Huuk, et al. (2016)
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Hahn, Huuk, et al. (2016); Huuk
et al. (2016)
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developed by Zhu et al. (2014). Separate templates for light and
heavy chains were selected based on the sequence identity of fra-
mework regions. For WT, M1, M2, the framework region templates
were 3SO3 and 3T2N (PDB accession codes) for heavy and light
chains, respectively. Comparably low sequence identity (<40%)
between available templates and the 14 residues long H‐CDR3
demanded an ab initio structure prediction using the Prime method
(Zhu & Day, 2013). Following the method developed by Zhu et al.
(2014), all structures were prepared accordingly before starting loop
prediction. Structure preparation included the assignment of polar
hydrogen positions, protonation states, and energy minimization
using the OPLS3e force field (Roos et al., 2019). Surface patches and
protein descriptors were calculated within BioLuminate, at pH 5.25
(Olsson et al., 2011; Sankar, Krystek, et al., 2018).
2.3 | Mechanistic chromatography modeling
The simulation software ChromX (GoSilico GmbH) was used for
mechanistic chromatography modeling. The transport dispersive
model in Equation (1) was applied as a column model (Baumann
et al., 2015; Hahn, Huuk, et al., 2016). In Equation (1), the change of
the concentration ci(x, t) is a function of the convective mass trans-
port in the interstitial volume of the packed bed with the superficial
velocity u. Furthermore, the model considers axial dispersion Dax
effects and interfacial mass transfer between the interstitial volume
defined by the bed porosity εcol and the particle pores. Film diffusion
effects in the particle boundary layer and pore diffusion in the par-
ticle phase are expressed by the effective mass transfer parameter
keff, i. Equation (2) represents the accumulation of mass in the pore
volume ci and the stationary phase qi. Danckwerts' boundary con-
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Protein adsorption is modeled using the SMA isotherm (Brooks
& Cramer, 1992). Equation (5) shows the kinetic form of the SMA
isotherm modified by Hahn, Baumann, et al. (2016), where qi and cp, i
denote the protein concentration in the solid and liquid phase of the
particle, respectively. The SMA model formulates the equilibrium
binding behavior of the protein considering the salt concentration in
the pore phase cs, the ionic capacity of the resin Λ and protein‐
specific model parameters. The protein characteristic charge νi ac-
counts for the number of charges interacting with the resin, while
steric shielding σi considers the number of functional groups on the
resin blocked by the protein due to steric hindrance. Additionally, the
constants keq, i = kads, i/kdes, i, and kkin, i = 1/kdes, i comprise adsorption
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Estimation of protein‐specific model parameters is the first step,
before a mechanistic model can be applied to real‐world tasks in DSP
development. The Yamamoto method enabled the analytical solution
of νi and keq, i using a set of LGEs at differing salt gradient slopes.
Equation (7) describes the linear relationship between the normal-
ized gradient slope GH and the elution salt concentration cs, i of
component i at diluted loading conditions (Ishihara et al., 2005;
Osberghaus et al., 2012; Rüdt et al., 2015; Yamamoto et al., 1987;
Yamamoto et al., 1988). Equations (8) and (9) lead to the calculation
of the normalized gradient slope GH, where cs, initial is the salt con-
centration at the gradient begin, cs, final is the salt concentration at
the gradient end, and VG is the gradient length in milliliters. The
isotherm parameters defining the nonlinear region of the SMA iso-
therm, kkin, i and σi, were estimated using the inverse method de-
veloped by Hahn, Baumann, et al. (2016) and Hahn, Huuk,
et al. (2016).
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3 | RESULTS
3.1 | Process behavior and protein surface
analysis
The aim of the present study was to analyze the effects of single
amino acid substitutions in the CDR of an mAb on process behavior
in CEX chromatography. The two mutants M1 and M2 had an ad-
ditional positively charged group in the CDR compared with the WT
mAb. Details on amino acid substitutions are given in Section 2.1. An
identical set of preparative CEX experiments was performed for
three mAb variants. In this section, the results of LGE experiments
under low loading conditions (1 g/LResin) are compared to the in silico
analysis of corresponding homology models. Figure 1d,f show LGE
experiments at a gradient length of 20 column volumes (CV) and
mobile phase pH 5.25. The WT antibody eluted first, followed by the
mutants M1 and M2 with additional positively charged amino acid
side chains in the CDR. WT, M1, and M2 eluted at a sodium counter‐
ion concentration of 0.336, 0.416, and 0.433M during salt gradient
elution, respectively. Besides the delayed retention volume, similar
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peak shapes could be observed for the WT and M1. In contrast, M2
showed an increased elution pool volume compared to WT and M1,
caused by a distinct pre‐peak with shoulder. Results of analytical
chromatography (HP‐CEX) indicated that the pre‐peak of M2 was
caused by an increased charge heterogeneity of the loading material
(data not shown).
The visible effect of point mutations in the CDRs on the elution
behavior during CEX chromatography demanded a thorough in-
vestigation of structural characteristics causing these phenomena.
Homology models were calculated for the three IgG1 mAbs using the
workflow described in Section 2.2. Antibody structure predictions in
Figure 1a–c confirmed that the substituted side chain residues were
solvent‐exposed. Due to identical Fc regions, protein surface analysis
was performed for the Fab only, while the pI and net charge calcu-
lations were based on full‐length homology models. Table 2 com-
pares pI values obtained via capillary isoelectric focusing (cIEF) with
in silico predicted pI values and protein descriptors. Both, in silico
and wet‐lab experiments, could not measure significant differences
between pI values of the three mutants. Model‐based net charge of
the full‐length IgG1 mutants at pH 5.25 increased to 50 from 48. The
number of positive charges per CDR increased to 7 from 6 for the
mutated mAbs at pH 5.25. Additionally, compared with WT, point
mutations increased the sum energy of positive surface patches
larger than 30 Å2 in the CDRs by 20% and 28% for M1 and M2,
F IGURE 1 Protein surface analysis and elution behavior in cation‐exchange (CEX) chromatography at 1 g/LResin loading density. Predicted
Fv homology models: (a) wild type (WT) with tryptophan in the heavy chain (HC) and serine in the light chain (LC); (b) M1 with tryptophan in HC
and lysine in LC; (c) M2 with lysine in HC and serine in LC. The solvent‐exposed surface is shown as mesh, and positively charged patches close
to H‐CDR3 (purple) and L‐CDR3 (dark green) are marked in blue. (d–f) Respective CEX chromatograms of linear salt gradient elution
experiments conducted on POROS XS at pH 5.25, with 20 column volume gradient length, and a flow velocity of 200 cm/h [Color figure can be
viewed at wileyonlinelibrary.com]
SALEH ET AL. | 2927
respectively. Protein surface analysis in Figure 1 visualizes the ad-
ditional positively charged patches in the CDR of mutated mAbs. Due
to the high degree of solvent exposure, all depicted surface patches
could potentially be involved in the adsorption process. For M1,
serine was substituted with lysine, adding a positive patch in a
neutral region of the WT mAb. Besides the differences in positive
surface charges, ab initio H‐CDR3 loop prediction via the Prime
method (Zhu & Day, 2013) resulted in similar conformations for WT
and M1. In contrast, the substitution of tryptophan with lysine in M2
influenced the predicted conformation of the H‐CDR3, increasing
solvent exposure compared with WT and M1.
3.2 | Chromatography modeling
Homology modeling and protein surface analysis provided insights
into the structural properties of the mAbs leading to differences in
their chromatographic behavior. Mechanistic chromatography mod-
eling aims to increase process understanding on a macroscopic level
by describing the physical effects in the chromatographic system.
This section investigates the effects of changes in the protein
structure on macroscopic adsorption model parameters.
System and column characterization were crucial for the fol-
lowing estimation of protein‐specific model parameters. All results
and respective methods of column characterization and are listed in
Table 1. POROS XS is a perfusion resin, with comparably low mass
transfer resistance. Therefore, keff, salt was approximated with
rP/3 = 0.0083mm/s (Rodrigues, 1997). For the protein species, the
penetration correlation (Guiochon et al., 2006) enabled the calcula-
tion of effective mass transfer parameters keff, i depending on the
hydrodynamic radii of the mAbs and the linear flow rate. Identical
hydrodynamic radii of 73 Å were computed based on full‐length
homology models resulting in a keff,i of 0.0013mm/s for WT, M1, and
M2. Predictions of the height and width of elution peaks at low
loading conditions validated assumptions regarding the mass trans-
fer of protein.
Multiple lab‐scale experiments for each mAb allowed the esti-
mation of SMA model parameters. Table 3 summarizes the resulting
isotherm parameters. Five LGE experiments were conducted at
1 g/LResin loading density and altering gradient lengths between
10 and 30CV. At each gradient slope, the WT eluted first followed by
M1 and M2. Figure 2 visualizes the Yamamoto correlation (Equation 7),
which enabled the analytical solution of the characteristic charge νi and
equilibrium constant keq, i based on the five LGE experiments per mAb.
The parallel regression lines in Figure 2 resulted in comparable char-
acteristic charge νi. In addition, the predicted and measured net
charges and pI values of the homology models in Table 2 did not show
a considerable difference between the molecules. In contrast to νi, the
equilibrium constants keq, i of the mutants M1 and M2 in Table 3 in-
creased to approximately 8‐ and 23‐fold compared with the WT, re-
spectively. The characteristic charge νi and the equilibrium constant
keq, i have a similar effect on the retention volume during LGE elution at
low loading densities. Thus, the equilibrium constant keq, i was the
parameter affected by the addition of positively charged groups in the
CDR and caused the shifts in retention volume.
Steric shielding σi and kinetic kkin ,i, the remaining model para-
meters defining the nonlinear region of the SMA isotherm, were
estimated using the inverse method introduced by Hahn, Baumann,
et al. (2016). Here, the model output was fitted to the UV signal at
280 nm wavelength of the high load LGE runs in Figure 3. Similar to
keq, i, the kinetic parameter kkin, i increased for the mutated mAbs.
The shielding parameters in Table 3 show that the substitution of
tryptophan with lysine in M2 reduced σi by 28% compared with the
WT. The single protein species defined for WT and M1 was able to
describe peak shapes and retention volumes at 30 g/LResin loading
density. For M2, the increased concentration of acidic charge var-
iants demanded the consideration of additional protein species. Two
acidic peak groups (APG1 and APG2) of M2 were defined based on
the peak‐to‐peak ratios measured at the low loading density LGE
experiments. The relative input composition of M2 main, M2 APG1,
and M2 APG2 was 67%, 16%, and 17%, respectively. Single amino
acid substitutions could not affect the characteristic charge para-
meters of WT, M1, and M2 in a magnitude that would describe the
differences in retention volume. Thus, the characteristic charge νi of
the M2 charge variants, APG1 and APG2, was assumed to be equal
to the characteristic charge of the M2 main species.
TABLE 2 Molecular descriptors and pI values obtained via in
silico prediction and cIEF measurements









Method In silico cIEF In silico In silico In silico
WT 9.2 8.9 48 6 499
M1 9.2 8.9 50 7 599
M2 9.2 8.9 50 7 638
Abbreviations: CDR, complementarity‐determining region; cIEF, capillary
isoelectric focusing; WT, wild type.
aIn silico descriptors were calculated based on homology models at
pH 5.25.
TABLE 3 SMA isotherm parameters of WT, M1, and M2 at pH
5.25 on POROS XS
νi (−) keq, i (−) kkin, i (sMν) σi (−)
WT 11.7 0.08 4.58E−05 53
M1 11.6 0.65 3.41E−04 51
M2 Main 11.9 1.82 4.09E−04 38
M2 APG1 11.3 0.65 1.05E−04 38
M2 APG2 11.3 0.15 2.74E−04 38
Note: Acidic charge variants of M2 were lumped in two APG based on
their retention time in preparative chromatography.
Abbreviations: APG, acidic peak group; SMA, steric mass‐action; WT,
wild type.
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For all three molecules, the transport‐dispersive SMA model
could describe the UV signal. This indicates that the selected
model captured relevant physical effects within the chromato-
graphic system. The comparison of isotherm parameters in
Table 3 with structural descriptors in Table 2 shows that mac-
roscopic adsorption model parameters are directly affected by
single amino acid substitutions and the resulting protein struc-
ture. Besides, the identified effects on mechanistic model para-
meters, amino acid substitutions influenced process performance
at both, low‐ and high‐loading densities. Retention times, charge
heterogeneity, and elution pool volumes in preparative column
experiments differed between the three mAb variants. Thus, lead
optimization can potentially affect preparative purification using
CEX chromatography.
4 | DISCUSSION
During the last years, a significant body of research has focused on
the development of in silico tools for the reduction of aggregation
propensity, improvement of solution properties, and optimization of
biological activity of therapeutic mAbs (Bauer et al., 2020; Kumar
et al., 2018; van der Kant et al., 2017). Optimization of protein sta-
bility has been shown to be associated with additional favorable
CMC properties, for example, increased expression titers during
upstream processing (Bauer et al., 2020; van der Kant et al., 2017).
The present study aimed to investigate the effects of single amino
acid substitutions in full‐length mAbs on the process behavior during
preparative CEX chromatography.
Previous work indicated that mAbs bind with their Fab first to
strong CEX media (Ishihara et al., 2005; Zhou et al., 2004). In this
study, modification of CDR residues that contribute to positive
patches on the mAb surface proved the vital role of the Fab and CDR
in antibody adsorption on strong CEX media. An identical set of
preparative CEX experiments with three mAb variants differing in a
single amino acid showed a correlation between the sum positive
patch energy of the CDR and retention time during gradient elution.
Independent of CDR loop confirmations, the substitution of trypto-
phan with lysine in the H‐CDR3 of M2 increased the elution salt
concentration by 32%. This resulted in comparably high salt con-
centrations in the product pool. The final salt concentration in the
product pool needs to be considered in designing the process se-
quence, when combining CEX with other chromatographic modalities
for mAb polishing. Thus, the exchange of a single charged amino acid
during lead optimization has the potential to affect resin selection
and process design during downstream processing. Despite differ-
ences in patch energies and CEX retention times, pI values and net
charges of the homology model did not differ significantly between
investigated mAbs. While this may seem trivial due to the minimal
variation in primary structure, it is important to notice that the ex-
perimental pI value is often considered as initial binding strength
indicator for the development of IEX chromatography processes.
Previous studies could show that solvent‐exposed charges on the
mAb surface are relevant for protein adsorption in IEX and mixed‐
mode chromatography (Gudhka et al., 2020; Ishihara et al., 2005;
J. Robinson et al., 2018). In this study, targeted amino‐acid sub-
stitutions within the protein–resin interaction surface emphasized
that inhomogeneous charge distribution affects chromatographic
F IGURE 2 Model calibration for the linear region of the steric mass‐action isotherm. Yamamoto method for linear salt gradient elution
experiments with 10, 15, 20, 25, 30 column volume gradient length at pH 5.25 on the strong cation exchange media POROS XS. Slope and
intercept of linear regressions enabled the calculation of characteristic νi and keq, i equilibrium constant, respectively. R
2 > 0.98 for all linear
regressions
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behavior of proteins with almost identical net charges. Therefore,
local and global molecule properties should be considered equally in
the design of IEX chromatography processes, especially for large
multidomain molecules such as mAbs. Nonetheless, the unraveled
correlations and binding orientation are only valid for the in-
vestigated strong CEX media. In contrast to our data, Müller‐Späth
et al. (2008) separated mAbs with differing numbers of C‐terminal
lysine using an analytical weak CEX media at pH 6.3. Their data
suggests that the Fc part of mAbs contributes to protein adsorption
on weak CEX media. Consequently, protein adsorption is equally
dependent on the molecule structure and the chromatographic li-
gand. Future studies are required to shed light on the correlations
between antibody structure and process behavior in other chroma-
tographic unit operations.
Besides the shift in retention volume, the substitution of tryp-
tophan with lysine in the H‐CDR3 of M2 had a significant effect on
the percentage of acidic charge variants and the resulting elution
profiles in Figures 1 and 3. Interestingly, ab initio H‐CDR3 structure
prediction using Prime method (Zhu & Day, 2013) resulted in an
increased solvent exposure of the M2 H‐CDR3 compared with the
WT and M1 mAbs (Figure 1). Recently, Lan et al. (2020) reported an
anomalous charge variant profile of an IgG1 mAb in analytical CEX
chromatography caused by two discrete conformational states of the
H‐CDR3. Their analytical and molecular modeling investigation re-
vealed a pH‐dependent equilibrium between “open” and “closed”
conformational states of the H‐CDR3. Furthermore, their work
identified a neighboring tryptophan residue in the LC showing re-
duced solvent exposure at lower pH values. Previous work under-
lined that aromatic and hydrophobic groups have a stabilizing effect
on CDR loop conformation (van der Kant et al., 2019). Therefore, it
can be assumed that the substitution of tryptophan with lysine in M2
destabilized the energetically favored loop conformation and in-
creased solvent exposure of the H‐CDR3 (Figure 1). Charge het-
erogeneity is a common feature of therapeutic mAbs, which does not
necessarily influence their efficacy (Lan et al., 2020; H. Liu
et al., 2008). However, when comparing the results to previous work
(Saleh et al., 2020), the distinct peak shoulder in the chromatograms
of M2 is uncommon for IgG1 mAbs in preparative CEX chromato-
graphy. When applying identical UV‐based collection criteria to the
three mAb variants, the elution pool volume of M2 increases by
~33% compared with WT and M1. Due to limited tank capacities in
manufacturing facilities and processing time related to the sub-
sequent product concentration via ultrafiltration/diafiltration, the
high elution pool volume represents an undesired CMC property.
Hence, the substitution of potentially stabilizing, aromatic groups
within the H‐CDR3 should be avoided during lead optimization.
Based on these findings, mAb candidates with favorable CMC
properties can be selected for a streamlined process development.
Alternatively, a qualitative prediction of protein adsorption based on
the sequence may allow an early estimation of experimental efforts
necessary for developing polishing chromatography. In case an mAb
shows a high likelihood for unfavorable CMC properties in CEX
chromatography, for example, increased elution pool volumes or high
salt concentration in the elution pool, a broad resin screening with
differing chromatographic modalities can be planned early during
process development. For a holistic DSP developability assessment,
additional unit operations should be added to the multiscale mod-
eling workflow. However, our results indicate that CEX chromato-
graphy is sensitive to minimal changes in the primary structure of
F IGURE 3 Comparison of simulated and measured
chromatograms of the cation exchange process under nonlinear
loading conditions. Linear salt gradient elution experiments on
POROS XS at 30 g/LResin loading density, with 30 CV gradient length,
and a flow velocity of 200 cm/h. The blue dashed lines indicate
simulated sum signals. Solid lines represent experimental data. (a)
WT; (b) M1. For WT and M1, a single protein species was simulated.
(c) M2. Three protein species were considered in the simulation of
the M2 process. Green and cyan dashed lines are simulations of
acidic charge variants of M2 [Color figure can be viewed at
wileyonlinelibrary.com]
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mAbs. For other unit operations in common DSP platforms, for ex-
ample, filtration steps, Protein A affinity chromatography, or anion
exchange chromatography in flow‐through mode, amino acid sub-
stitutions during lead optimization are less likely to have significant
effects on the process performance. Thus, the developed in silico
workflow supports one of the most development‐intensive unit op-
erations in our DSP platform. Future work should investigate how
the identified correlations integrate into a holistic CMC develop-
ability assessment combining upstream, downstream, and formula-
tion parameters.
The results in Section 3.2 confirmed a relationship between
mAb structure and adsorption model parameters. Due to the
semimechanistic nature of the commonly applied SMA adsorp-
tion model, an interpretation of model parameters is challenging,
especially for multidomain molecules such as mAbs. The multi-
component SMA adsorption model (Brooks & Cramer, 1992) is an
extension of the stoichiometric displacement concept developed
by Boardman and Partridge (1955). Here, the characteristic
charge describes multipoint binding of proteins on charged sur-
faces. In Section 3.2, the introduction of two additional charges
per mAb could not increase the characteristic charge parameters
of M1 and M2 in a magnitude that describes the shift in retention
time. When comparing the constant νi parameters to constant pI
values and protein net charges in Table 2, the characteristic
charge can be assumed to describe the average number of posi-
tive patches on the protein surface interacting with the resin. In
contrast to the characteristic charge, the equilibrium constant
keq, i was significantly increased by the introduction of positively
charged groups within the adsorption‐mediating region on the
protein surface. Therefore, keq, i may define the strength of the
anisotropic adsorption reaction, depending on positive patches in
mAb CDR. Substitution of the tryptophan residue in M2 reduced
the steric shielding parameter σi. The reduction of σi could have
been caused by a combination of two effects. First, the con-
formational change of the H‐CDR3 could have reduced the
number of ligands blocked by the protein. Additionally, it has
been observed that the steric shielding parameter can also de-
scribe repulsive effects on the resin surface (Ladiwala
et al., 2005). Thus, the substitution of the aromatic tryptophan
residue could have influenced hydrophobic interactions with the
resin backbone leading to a reduced σM2 compared with σWT.
The knowledge gained on structural dependencies of model
parameters could support the selection of plausible boundary con-
ditions for model parameter estimation, which is crucial for avoiding
local minima (Rischawy et al., 2019). Despite the influence of amino
acid substitutions on adsorption model parameters, the data set is
still limited to three variants of a monoclonal antibody. When in-
creasing size and structural heterogeneity of the mAb data set, the
found correlations could enable QSPR modeling for the prediction of
SMA parameters. Conventional QSPR approaches for developability
assessment correlate structural properties with specific performance
indicators or quality attributes of the biopharmaceutical (Jetha
et al., 2018; Sankar, Hoi, et al., 2018). A structure‐based prediction of
adsorption model parameters could lead to a full digital re-
presentation of the unit operation enabling the simulation of an
unlimited number of process conditions before material for wet‐lab
CMC activities is available.
5 | CONCLUSION
Our results demonstrate that sequence optimization of mAb
candidates can influence downstream processing. Single amino
acid substitutions in the CDR had a significant impact on reten-
tion volumes and elution profiles during preparative CEX chro-
matography. The findings enable a relative classification of mAb
candidates in weak, medium, and strong adsorption to CEX media
based on the number of positively charged amino acid side chains
in the CDR. Substitution of tryptophan with lysine destabilized
the H‐CDR3 loop conformation, leading to an increased charge
heterogeneity and broadened elution profiles in CEX chromato-
graphy. The identified relationship between mAb primary struc-
ture and CMC properties may support the selection of mAb
candidates that integrate into common downstream platforms.
Furthermore, a structure‐based estimation of mAb elution
behavior in CEX chromatography could be used to plan initial
experiments during early‐phase DSP development. Effects of
amino acid substitutions on semimechanistic adsorption model
parameters underline the possibility of building QSPR models
that support the calibration of mechanistic chromatography
models. Our results could promote a paradigm shift in DSP
development from a strictly generic platform process to a more
flexible process design driven by the structural characteristics of
the mAb.
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